ArticleJACC. Case reports2026
Minimum-Radiation Percutaneous Coronary Intervention for Pregnant Woman With Acute Coronary Syndrome.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute coronary syndrome during pregnancy is rare with limited evidence; management must be tailored to safeguard both mother and fetus. CASE SUMMARY: A 40-year-old woman with type 2 diabetes presented with acute coronary syndrome at 11+3 weeks' gestation. She underwent intracoronary imaging-guided percutaneous coronary intervention (PCI) (3.0- × 28-mm stent, mean external elastic lamina diameter: 3.07 mm, lesion length: 28 mm) under minimal radiation (estimated fetal dose: ≈0.00004 mGy). After optimal stent implantation, 6 weeks of dual antiplatelet therapy with aspirin and clopidogrel were followed by lifelong aspirin. Pregnancy was uncomplicated with healthy infant delivered at 39 weeks. Postpartum angiography confirmed good result, and statin was initiated. DISCUSSION: Intracoronary imaging-guided PCI enables precise diagnosis and tailored therapy with reduced radiation exposure. Drug regimens balance maternal benefit and fetal safety. TAKE-HOME MESSAGES: Intracoronary imaging-guided PCI allows precise and safe treatment in pregnant ACS patients. Drug therapy must be adapted to avoid fetal risk while ensuring maternal protection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.